← 產業報告目錄

Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, Gene Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Data Analysis), Application (Drug discovery & Development, Clinical Diagnostics), End User, and Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-04-15頁數 511報告編號 BT2236

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The gene expression analysis market is expected to reach USD 5.93 billion in 2031 from USD 4.23 billion in 2026, at a CAGR of 7.0% during the forecast period. The market is driven by the increasing adoption of transcriptomics technologies and the growing focus on precision medicine and personalized therapeutics. Techniques such as next-generation sequencing, PCR, and microarrays enable accurate and high-throughput analysis of gene activity, supporting advancements in disease research and diagnostics. Furthermore, the rising use of gene expression profiling in biomarker discovery and drug development enhances research efficiency and clinical outcomes. However, high instrument costs, complex data analysis, and the need for skilled professionals continue to limit market growth. “The reagents & consumables segment is expected to grow at the highest CAGR during the forecast period.” The reagents & consumables segment is projected to grow at the highest CAGR in the gene expression analysis market due to the repeated and high-volume usage of kits, enzymes, probes, and other consumables across research and clinical workflows. These products are essential for techniques such as PCR, next-generation sequencing, and microarray analysis, ensuring consistent demand. The increasing number of genomics and transcriptomics studies, along with the rising adoption of gene expression profiling in diagnostics and drug research, is further driving segment growth. Additionally, continuous product innovations and the need for reliable and high-quality reagents to ensure accurate results contribute to the expansion of this segment. Their cost-effectiveness and recurring purchase nature make reagents & consumables a key growth driver in the market. “Drug discovery & development segment holds the largest share of the market.” The drug discovery & development segment accounts for the largest share of the gene expression analysis market, driven by the extensive use of gene expression profiling in identifying and validating drug targets. These technologies play a critical role in understanding gene function, disease pathways, and therapeutic responses, thereby improving the efficiency of drug development processes. Pharmaceutical and biotechnology companies increasingly rely on gene expression analysis for biomarker discovery, toxicity assessment, and efficacy evaluation. The growing focus on precision medicine and targeted therapies, along with rising R&D investments, further supports the dominance of this segment. “The US is projected to grow at the highest CAGR during the forecast period.” The US is projected to grow at the highest CAGR in the gene expression analysis market due to its strong presence of leading biotechnology and pharmaceutical companies, advanced research infrastructure, and increasing focus on genomics and transcriptomics studies. Rising adoption of gene expression profiling in areas such as oncology, genetic disorders, and precision medicine is a key factor driving market growth. Technologies including next-generation sequencing, PCR, and microarrays are widely used across research and clinical applications, further boosting demand. Additionally, supportive regulatory frameworks, high funding for genomic research, and continuous advancements in analytical technologies contribute to market expansion. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side – 70% and Demand Side – 30% • By Designation: Managers – 45%, CXOs and Directors – 30%, and Executives – 25% • By Region: North America – 40%, Europe – 25%, Asia Pacific – 25%, Latin America – 5%, the Middle East & Africa – 5% Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), Danaher Corporation (US), Bruker (US), 10X Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), BioSpyder Technologies Inc. (US), and New England Biolabs (US) are some of the key companies offering gene expression analysis products & services. Research Coverage This research report categorizes the gene expression analysis market by offering (reagents & consumables[assays & kits, enzymes, DNA chips, other reagents & consumables], instruments [PCR, NGS, DNA microarray, other instruments], services [gene expression analysis services{RNA sequencing services, other services}, bioinformatics solutions]), application (drug discovery & development, clinical diagnostics, other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, And Africa). The report’s scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the gene expression analysis market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product portfolio, key strategies, new product launches, acquisitions, and recent developments related to the gene expression analysis market. This report also includes a competitive analysis of emerging startups in the gene expression analysis industry ecosystem. Key Benefits of Buying the Report The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (growing use of gene expression analysis in drug discovery and development, expanding applications in disease research, and rising adoption of gene expression–based diagnostics and prognostics tests), restraints (High cost of instruments and complexity of data analysis and interpretation), opportunities (growing adoption of single-cell analysis technologies and expansion of gene expression analysis in clinical and translational research), and challenges (lack of standardization) influencing the market growth • Product Development/Innovation: Detailed insights into newly launched products and innovations in the gene expression analysis market • Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the gene expression analysis market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products & services of leading players, Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), among others, for the gene expression analysis market
目錄 Table of Contents
1 INTRODUCTION 44 1.1 STUDY OBJECTIVES 44 1.2 MARKET DEFINITION 44 1.3 STUDY SCOPE 44 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 45 1.3.2 INCLUSIONS & EXCLUSIONS 46 1.3.3 YEARS CONSIDERED 46 1.3.4 CURRENCY CONSIDERED 47 1.4 STAKEHOLDERS 47 1.5 SUMMARY OF CHANGES 47 2 EXECUTIVE SUMMARY 49 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 49 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 50 2.3 DISRUPTIVE TRENDS IN GENE EXPRESSION ANALYSIS MARKET 51 2.4 HIGH-GROWTH SEGMENTS 52 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 53 3 PREMIUM INSIGHTS 54 3.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 54 3.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING 55 3.3 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56 3.4 GENE EXPRESSION ANALYSIS MARKET SHARE, BY OFFERING, 2026 VS 2031 (%) 56 4 MARKET OVERVIEW 57 4.1 INTRODUCTION 57 4.2 MARKET DYNAMICS 58 4.2.1 DRIVERS 59 4.2.1.1 Growing use of gene expression analysis in drug discovery and development 59 4.2.1.2 Expanding applications in disease research 59 4.2.1.3 Rising adoption of gene expression-based diagnostics and prognostics tests 60 4.2.2 RESTRAINTS 60 4.2.2.1 High cost of instruments 60 4.2.2.2 Complexity of data analysis and interpretation 61 4.2.3 OPPORTUNITIES 61 4.2.3.1 Growing adoption of single-cell analysis technologies 61 4.2.3.2 Expansion of gene expression analysis in clinical and translational research 62 4.2.4 CHALLENGES 62 4.2.4.1 Lack of standardization 62 4.3 UNMET NEEDS AND WHITE SPACES 63 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 63 4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 64 5 INDUSTRY TRENDS 65 5.1 PORTER’S FIVE FORCES ANALYSIS 65 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 66 5.1.2 BARGAINING POWER OF SUPPLIERS 66 5.1.3 BARGAINING POWER OF BUYERS 67 5.1.4 THREAT OF SUBSTITUTES 67 5.1.5 THREAT OF NEW ENTRANTS 67 5.2 MACROECONOMIC OUTLOOK 67 5.2.1 INTRODUCTION 67 5.2.2 GDP TRENDS AND FORECAST 67 5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY 68 5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY 68 5.3 VALUE CHAIN ANALYSIS 68 5.4 ECOSYSTEM ANALYSIS 70 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 71 5.5 PRICING ANALYSIS 72 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025 (USD) 73 5.5.1.1 Instruments 73 5.5.1.2 Consumables 74 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 75 5.5.2.1 Instruments 75 5.5.2.2 Consumables 76 5.6 TRADE ANALYSIS 77 5.6.1 IMPORT SCENARIO (HS CODE 3822.00) 77 5.6.2 EXPORT SCENARIO (HS CODE 3822.00) 78 5.6.3 IMPORT SCENARIO (HS CODE 9027.00) 79 5.6.4 EXPORT SCENARIO (HS CODE 9027.00) 80 5.7 KEY CONFERENCES & EVENTS, 2026–2027 81 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 81 5.9 INVESTMENT & FUNDING SCENARIO 82 5.10 CASE STUDY ANALYSIS 83 5.10.1 RNA SEQUENCING ENABLES CLINICAL DIAGNOSTIC ADVANCEMENTS IN RARE GENETIC DISORDERS 83 5.10.2 TRANSCRIPTOMIC PROFILING IMPROVES BIOMARKER DETECTION IN ONCOLOGY 83 5.10.3 GENE EXPRESSION ANALYSIS ENABLES FUNCTIONAL INTERPRETATION IN RARE DISEASE DIAGNOSTICS 84 5.11 IMPACT OF US TARIFFS—GENE EXPRESSION ANALYSIS MARKET 84 5.11.1 INTRODUCTION 84 5.11.2 KEY TARIFF RATES 84 5.11.3 PRICE IMPACT ANALYSIS 85 5.11.4 IMPACT ON COUNTRIES/REGIONS 86 5.11.4.1 US 86 5.11.4.2 Europe 86 5.11.4.3 Asia Pacific 87 5.11.5 IMPACT ON END-USE INDUSTRIES 87 5.11.5.1 Pharmaceutical & biotechnology companies 87 5.11.5.2 CROs and academic & research institutes 87 5.11.5.3 Clinical laboratories 88 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 89 6.1 INTRODUCTION 89 6.2 KEY TECHNOLOGIES 89 6.2.1 QUANTITATIVE PCR (QPCR) 89 6.2.2 MICROARRAY TECHNOLOGY 89 6.2.3 RNA SEQUENCING 90 6.3 ADJACENT TECHNOLOGIES 90 6.3.1 SINGLE-CELL ANALYSIS 90 6.3.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 90 6.3.3 SPATIAL BIOLOGY 91 6.4 TECHNOLOGY ROADMAP 91 6.5 PATENT ANALYSIS 92 6.5.1 METHODOLOGY 92 6.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 92 6.5.3 LIST OF KEY PATENTS 94 6.6 FUTURE APPLICATIONS 95 6.7 IMPACT OF AI/GEN AI ON GENE EXPRESSION ANALYSIS MARKET 95 6.7.1 TOP USE CASES AND MARKET POTENTIAL 96 6.7.2 BEST PRACTICES IN AI-ENABLED GENE EXPRESSION WORKFLOWS 97 6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET 97 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 97 6.7.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET 98 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 99 7.1 REGIONAL REGULATIONS AND COMPLIANCE 99 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 7.1.2 INDUSTRY STANDARDS 101 7.1.2.1 North America 101 7.1.2.2 Europe 102 7.1.2.3 Asia Pacific 102 7.1.2.4 Rest of the world 102 7.1.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 103 7.2 SUSTAINABILITY INITIATIVES 104 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 105 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 106 8.1 DECISION-MAKING PROCESS 106 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 106 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 106 8.2.2 BUYING CRITERIA 107 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 108 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 108 9 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING 110 9.1 INTRODUCTION 111 9.2 REAGENTS & CONSUMABLES 111 9.2.1 ASSAYS & KITS 115 9.2.1.1 Rising adoption of multi-omics and single-cell assay kits to drive market 115 9.2.1.2 RNA isolation kits 119 9.2.1.2.1 Increasing demand for high-quality RNA and integrated multi-omics workflows to drive market 119 9.2.1.3 cDNA synthesis kits 123 9.2.1.3.1 Growing demand for high-fidelity reverse transcription in advanced transcriptomics to drive market 123 9.2.1.4 Library preparation kits 126 9.2.1.4.1 Increasing adoption of high-throughput sequencing and multiomics workflows to drive market 126 9.2.1.5 PCR assays & kits 130 9.2.1.5.1 Expanding use of PCR-integrated workflows in diagnostics and precision medicine to drive market 130 9.2.1.6 Other assays & kits 133 9.2.2 ENZYMES 136 9.2.2.1 Advancements in high-fidelity, application-specific enzymes to drive market 136 9.2.3 DNA CHIPS 140 9.2.3.1 Increasing adoption of high-throughput DNA chips in large-scale genomics research to propel market 140 9.2.4 OTHER REAGENTS & CONSUMABLES 143 9.3 INSTRUMENTS 147 9.3.1 PCR INSTRUMENTS 150 9.3.1.1 Increasing adoption of high-precision and automated PCR technologies to boost demand 150 9.3.2 NGS INSTRUMENTS 153 9.3.2.1 Expanding adoption of high-throughput NGS platforms to drive market 153 9.3.3 DNA MICROARRAY SCANNERS 156 9.3.3.1 Enhanced microarray performance and throughput to propel market 156 9.3.4 OTHER INSTRUMENTS 160 9.4 SOFTWARE & SERVICES 163 9.4.1 GENE EXPRESSION ANALYSIS SERVICES 167 9.4.1.1 RNA sequencing services 171 9.4.1.1.1 Expanding transcriptomics research to propel market 171 9.4.1.2 Microarray analysis services 174 9.4.1.2.1 Increasing demand for standardized, high-throughput gene expression profiling in large-sample studies to propel market 174 9.4.1.3 qPCR profiling services 178 9.4.1.3.1 Increasing demand for precise gene expression quantification to propel market 178 9.4.1.4 Other gene expression analysis services 181 9.4.2 BIOINFORMATICS SOLUTIONS 185 9.4.2.1 Rising demand for AI-driven bioinformatics solutions to support market growth 185 9.4.2.2 Bioinformatics & data analysis services 189 9.4.2.2.1 Rising complexity of multi-omics data and demand for AI-driven biological insights to drive market 189 9.4.2.3 Software 192 9.4.2.3.1 Gene expression databases 195 9.4.2.3.1.1 Increasing need for structured data management to drive market 195 9.4.2.3.2 Data analysis software & visualization tools 198 9.4.2.3.2.1 Increasing demand for simplified data analysis and effective visualization of complex gene expression datasets to drive market 198 9.4.2.3.3 Cloud-based analysis platforms 202 9.4.2.3.3.1 Increasing shift toward AI-enabled SaaS cloud ecosystems to drive market 202 10 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 205 10.1 INTRODUCTION 206 10.2 DRUG DISCOVERY & DEVELOPMENT 206 10.2.1 INCREASING AI-INTEGRATED TRANSCRIPTOMICS AND PRECISION MEDICINE TO PROPEL MARKET 206 10.3 CLINICAL DIAGNOSTICS 210 10.3.1 INTEGRATION OF AI-DRIVEN ANALYSIS AND ADVANCED MOLECULAR DIAGNOSTICS TO DRIVE MARKET 210 10.4 BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS 213 10.4.1 EXPANDING MULTI-OMICS RESEARCH AND AI-ENABLED BIOINFORMATICS PLATFORMS TO DRIVE MARKET 213 10.5 OTHER APPLICATIONS 217 11 GENE EXPRESSION ANALYSIS MARKET, BY END USER 220 11.1 INTRODUCTION 221 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 221 11.2.1 STRATEGIC PHARMA-TECH COLLABORATIONS TO DRIVE MARKET 221 11.3 ACADEMIC & RESEARCH INSTITUTES 225 11.3.1 EXPANSION OF OPEN-ACCESS GENOMIC RESOURCES TO PROPEL MARKET 225 11.4 HOSPITALS & CLINICAL LABORATORIES 228 11.4.1 INTEGRATION OF PRECISION ONCOLOGY TO PROPEL MARKET 228 11.5 CONTRACT RESEARCH ORGANIZATIONS (CROS) 232 11.5.1 INCREASING OUTSOURCING OF COMPLEX GENOMIC RESEARCH AND CLINICAL TRIALS TO PROPEL MARKET 232 11.6 OTHER END USERS 235 12 GENE EXPRESSION ANALYSIS MARKET, BY REGION 239 12.1 INTRODUCTION 240 12.2 NORTH AMERICA 240 12.2.1 US 247 12.2.1.1 Rapid adoption of spatial transcriptomics and advanced genomics platforms to drive market 247 12.2.2 CANADA 252 12.2.2.1 Increasing incidence of chronic diseases to drive market 252 12.3 EUROPE 258 12.3.1 GERMANY 263 12.3.1.1 Expanding genomics infrastructure and advanced bioinformatics platforms to drive market 263 12.3.2 UK 268 12.3.2.1 National genomics initiatives and large-scale multiomics research to drive market 268 12.3.3 FRANCE 273 12.3.3.1 Increasing R&D in life sciences research to fuel market 273 12.3.4 ITALY 278 12.3.4.1 Expanding precision medicine research and adoption of advanced sequencing technologies to support market growth 278 12.3.5 SPAIN 283 12.3.5.1 Large-scale genomics programs to boost demand 283 12.3.6 REST OF EUROPE 288 12.4 ASIA PACIFIC 293 12.4.1 CHINA 299 12.4.1.1 Large-scale genomics program to boost demand 299 12.4.2 JAPAN 304 12.4.2.1 Integration of AI-driven genomics and precision oncology to propel market 304 12.4.3 INDIA 309 12.4.3.1 Expansion of national genomic databases to drive market 309 12.4.4 AUSTRALIA 314 12.4.4.1 National genomics integration to drive market 314 12.4.5 SOUTH KOREA 319 12.4.5.1 Government-led genomic data initiatives to boost demand 319 12.4.6 REST OF ASIA PACIFIC 324 12.5 LATIN AMERICA 329 12.5.1 BRAZIL 334 12.5.1.1 Growth in the biopharmaceutical industry to support market 334 12.5.2 MEXICO 339 12.5.2.1 Increasing incidence of diabetes and growing geriatric population to propel market 339 12.5.3 REST OF LATIN AMERICA 344 12.6 MIDDLE EAST 349 12.6.1 GCC COUNTRIES 353 12.6.1.1 Saudi Arabia 358 12.6.1.1.1 National genomics strategies and precision medicine integration to support market growth 358 12.6.1.2 United Arab Emirates 363 12.6.1.2.1 NGS-driven collaborations to fuel market 363 12.6.1.3 Rest of GCC Countries 368 12.6.2 REST OF MIDDLE EAST 373 12.7 AFRICA 378 12.7.1 EXPANDING GENOMICS RESEARCH CAPACITY AND DISEASE-FOCUSED INITIATIVES TO SUPPORT MARKET GROWTH 378 13 COMPETITIVE LANDSCAPE 384 13.1 INTRODUCTION 384 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 384 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023–MARCH 2026 384 13.3 REVENUE ANALYSIS, 2021–2025 386 13.4 MARKET SHARE ANALYSIS, 2025 387 13.5 BRAND COMPARISON 390 13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 391 13.6.1 STARS 391 13.6.2 EMERGING LEADERS 391 13.6.3 PERVASIVE PLAYERS 391 13.6.4 PARTICIPANTS 391 13.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 393 13.6.5.1 Company footprint 393 13.6.5.2 Region footprint 394 13.6.5.3 Offering footprint 395 13.6.5.4 Application footprint 396 13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 397 13.7.1 PROGRESSIVE COMPANIES 397 13.7.2 RESPONSIVE COMPANIES 397 13.7.3 DYNAMIC COMPANIES 397 13.7.4 STARTING BLOCKS 397 13.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 399 13.7.5.1 Detailed list of key startups/SMEs 399 13.7.5.2 Competitive benchmarking of key startups/SMEs 400 13.8 COMPANY VALUATION & FINANCIAL METRICS 401 13.8.1 COMPANY VALUATION 401 13.8.2 FINANCIAL METRICS 401 13.9 COMPETITIVE SCENARIO 402 13.9.1 PRODUCT LAUNCHES 402 13.9.2 DEALS 403 13.9.3 EXPANSIONS 403 14 COMPANY PROFILES 404 14.1 KEY PLAYERS 404 14.1.1 THERMO FISHER SCIENTIFIC INC. 404 14.1.1.1 Business overview 404 14.1.1.2 Products/Services offered 405 14.1.1.3 Recent developments 409 14.1.1.3.1 Product launches 409 14.1.1.3.2 Deals 410 14.1.1.3.3 Expansions 410 14.1.1.4 MnM view 410 14.1.1.4.1 Key strengths 410 14.1.1.4.2 Strategic choices 411 14.1.1.4.3 Weaknesses and competitive threats 411 14.1.2 BIO-RAD LABORATORIES, INC. 412 14.1.2.1 Business overview 412 14.1.2.2 Products/Services offered 414 14.1.2.3 Recent developments 417 14.1.2.3.1 Product launches 417 14.1.2.3.2 Deals 418 14.1.2.4 MnM view 418 14.1.2.4.1 Key strengths 418 14.1.2.4.2 Strategic choices 418 14.1.2.4.3 Weaknesses and competitive threats 418 14.1.3 ILLUMINA, INC. 419 14.1.3.1 Business overview 419 14.1.3.2 Products/Services offered 420 14.1.3.3 Recent developments 423 14.1.3.3.1 Product launches 423 14.1.3.3.2 Deals 424 14.1.3.4 MnM view 424 14.1.3.4.1 Key strengths 424 14.1.3.4.2 Strategic choices 424 14.1.3.4.3 Weaknesses and competitive threats 424 14.1.4 QIAGEN 425 14.1.4.1 Business overview 425 14.1.4.2 Products/Services offered 426 14.1.4.3 Recent developments 431 14.1.4.3.1 Product launches 431 14.1.4.3.2 Deals 431 14.1.4.4 MnM view 432 14.1.4.4.1 Key strengths 432 14.1.4.4.2 Strategic choices 432 14.1.4.4.3 Weaknesses and competitive threats 432 14.1.5 REVVITY 433 14.1.5.1 Business overview 433 14.1.5.2 Products/Services offered 434 14.1.5.3 Recent developments 436 14.1.5.3.1 Deals 436 14.1.5.3.2 Expansions 436 14.1.5.4 MnM view 436 14.1.5.4.1 Key strengths 436 14.1.5.4.2 Strategic choices 436 14.1.5.4.3 Weaknesses and competitive threats 437 14.1.6 F. HOFFMANN-LA ROCHE LTD. 438 14.1.6.1 Business overview 438 14.1.6.2 Products/Services offered 439 14.1.6.3 Recent developments 440 14.1.6.3.1 Product launches 440 14.1.6.3.2 Deals 441 14.1.6.3.3 Other developments 441 14.1.7 PACBIO 442 14.1.7.1 Business overview 442 14.1.7.2 Products/Services offered 443 14.1.7.3 Recent developments 444 14.1.7.3.1 Product launches 444 14.1.7.3.2 Deals 444 14.1.7.3.3 Expansions 445 14.1.8 AGILENT TECHNOLOGIES, INC. 446 14.1.8.1 Business overview 446 14.1.8.2 Products/Services offered 447 14.1.9 SYSMEX CORPORATION 451 14.1.9.1 Business overview 451 14.1.9.2 Products/Services offered 452 14.1.9.3 Recent developments 453 14.1.9.3.1 Deals 453 14.1.9.3.2 Other developments 453 14.1.10 BGI 454 14.1.10.1 Business overview 454 14.1.10.2 Products/Services offered 454 14.1.11 EUROFINS SCIENTIFIC 456 14.1.11.1 Business overview 456 14.1.11.2 Products/Services offered 457 14.1.12 STANDARD BIOTOOLS 458 14.1.12.1 Business overview 458 14.1.12.2 Products/Services offered 459 14.1.12.3 Recent developments 460 14.1.12.3.1 Product launches 460 14.1.13 OXFORD NANOPORE TECHNOLOGIES PLC 461 14.1.13.1 Business overview 461 14.1.13.2 Products/Services offered 462 14.1.13.3 Recent developments 463 14.1.13.3.1 Deals 463 14.1.13.3.2 Expansions 464 14.1.14 GENSCRIPT 465 14.1.14.1 Business overview 465 14.1.14.2 Products/Services offered 466 14.1.14.3 Recent developments 467 14.1.14.3.1 Deals 467 14.1.14.3.2 Expansions 467 14.1.15 TAKARA BIO INC. 468 14.1.15.1 Business overview 468 14.1.15.2 Products/Services offered 469 14.1.15.3 Recent developments 473 14.1.15.3.1 Product launches 473 14.1.15.3.2 Deals 474 14.1.16 DANAHER CORPORATION 475 14.1.16.1 Business overview 475 14.1.16.2 Products/Services offered 476 14.1.16.3 Recent developments 476 14.1.16.3.1 Deals 476 14.1.17 BRUKER 477 14.1.17.1 Business overview 477 14.1.17.2 Products/Services offered 479 14.1.17.3 Recent developments 479 14.1.17.3.1 Deals 479 14.2 OTHER PLAYERS 480 14.2.1 10X GENOMICS 480 14.2.2 ZYMO RESEARCH CORPORATION 481 14.2.3 TWIST BIOSCIENCE 482 14.2.4 PROMEGA CORPORATION 483 14.2.5 LGC LIMITED 485 14.2.6 CD GENOMICS 486 14.2.7 BIOSPYDER TECHNOLOGIES INC. 487 14.2.8 NEW ENGLAND BIOLABS 488 15 RESEARCH METHODOLOGY 491 15.1 RESEARCH DATA 491 15.1.1 SECONDARY DATA 492 15.1.1.1 Key data from secondary sources 492 15.1.2 PRIMARY DATA 493 15.1.2.1 Key data from primary sources 493 15.1.2.2 Key primary participants 493 15.1.2.3 Breakdown of primary interviews 493 15.1.2.4 Key industry insights 494 15.2 MARKET SIZE ESTIMATION 495 15.2.1 GLOBAL GENE EXPRESSION ANALYSIS MARKET ESTIMATION, 2025 495 15.2.2 SEGMENTAL MARKET SIZE ESTIMATION 498 15.3 MARKET GROWTH RATE PROJECTIONS 499 15.4 DATA TRIANGULATION 500 15.5 FACTOR ANALYSIS 501 15.6 RESEARCH ASSUMPTIONS 501 15.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 502 16 APPENDIX 503 16.1 DISCUSSION GUIDE 503 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 507 16.3 CUSTOMIZATION OPTIONS 509 16.4 RELATED REPORTS 509 16.5 AUTHOR DETAILS 510
圖表清單 List of Tables & Figures
TABLE 1 GENE EXPRESSION ANALYSIS MARKET: INCLUSIONS AND EXCLUSIONS 46 TABLE 2 GENE EXPRESSION ANALYSIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 58 TABLE 3 GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES 65 TABLE 4 GENE EXPRESSION ANALYSIS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 71 TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2023–2025 (USD) 73 TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023–2025 (USD) 74 TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2023–2025 (USD) 75 TABLE 8 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION, 2023–2025 (USD) 76 TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 77 TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 78 TABLE 11 IMPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 79 TABLE 12 EXPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 80 TABLE 13 GENE EXPRESSION ANALYSIS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027 81 TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US 84 TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 86 TABLE 16 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 92 TABLE 17 LIST OF KEY PATENTS IN GENE EXPRESSION ANALYSIS MARKET, 2023-2025 94 TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET 97 TABLE 19 CLIENT’S READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET 98 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 107 TABLE 25 KEY BUYING CRITERIA, BY END USER 107 TABLE 26 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 111 TABLE 27 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 112 TABLE 28 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 112 TABLE 29 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 30 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 31 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 32 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 33 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 115 TABLE 34 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 35 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 116 TABLE 36 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 37 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 38 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 39 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 40 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 118 TABLE 41 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 42 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 119 TABLE 43 RNA ISOLATION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 120 TABLE 44 NORTH AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 45 EUROPE: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 46 ASIA PACIFIC: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 47 LATIN AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 48 MIDDLE EAST: RNA ISOLATION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 122 TABLE 49 GCC COUNTRIES: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 50 CDNA SYNTHESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 51 NORTH AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 52 EUROPE: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 53 ASIA PACIFIC: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 54 LATIN AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 55 MIDDLE EAST: CDNA SYNTHESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 56 GCC COUNTRIES: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 57 LIBRARY PREPARATION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 127 TABLE 58 NORTH AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 59 EUROPE: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 60 ASIA PACIFIC: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 61 LATIN AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 62 MIDDLE EAST: LIBRARY PREPARATION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 129 TABLE 63 GCC COUNTRIES: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 64 PCR ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 65 NORTH AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 66 EUROPE: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 67 ASIA PACIFIC: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 68 LATIN AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 69 MIDDLE EAST: PCR ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 70 GCC COUNTRIES: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 71 OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 72 NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 73 EUROPE: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 74 ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 75 LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 76 MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 77 GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 78 GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 79 NORTH AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 80 EUROPE: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 81 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 82 LATIN AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 83 MIDDLE EAST: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 84 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 85 GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 86 NORTH AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 87 EUROPE: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 88 ASIA PACIFIC: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 89 LATIN AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 90 MIDDLE EAST: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 91 GCC COUNTRIES: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 92 OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 93 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 94 EUROPE: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 95 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 96 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 97 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 98 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 99 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 106 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 107 PCR INSTRUMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 108 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 109 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 110 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 111 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 112 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 113 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 114 NGS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 115 NORTH AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 116 EUROPE: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 117 ASIA PACIFIC: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 118 LATIN AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 119 MIDDLE EAST: NGS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 120 GCC COUNTRIES: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 121 DNA MICROARRAY SCANNERS MARKET, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 122 NORTH AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 123 EUROPE: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 124 ASIA PACIFIC: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 125 LATIN AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 126 MIDDLE EAST: DNA MICROARRAY SCANNERS MARKET, BY REGION 2024–2031 (USD MILLION) 159 TABLE 127 GCC COUNTRIES: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 128 OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 129 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 130 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 131 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 132 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 133 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 134 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 135 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 136 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 137 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 138 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 139 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 140 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 141 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 142 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 143 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 150 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 151 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 152 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 153 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 154 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 155 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 156 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 157 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 158 MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 159 NORTH AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 160 EUROPE: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 161 ASIA PACIFIC: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 162 LATIN AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 163 MIDDLE EAST: MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 164 GCC COUNTRIES: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 165 QPCR PROFILING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 166 NORTH AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 167 EUROPE: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 168 ASIA PACIFIC: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 169 LATIN AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 170 MIDDLE EAST: QPCR PROFILING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 171 GCC COUNTRIES: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 172 OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 173 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 174 EUROPE: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 175 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 176 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 177 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 178 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 179 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 181 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 182 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 183 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 184 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 185 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 186 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 187 GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 188 NORTH AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 189 EUROPE: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 190 ASIA PACIFIC: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 191 LATIN AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 192 MIDDLE EAST: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 193 GCC COUNTRIES: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 194 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 195 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 197 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 198 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 199 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 200 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 201 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 202 GENE EXPRESSION DATABASES MARKET, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 203 NORTH AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 204 EUROPE: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 205 ASIA PACIFIC: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 206 LATIN AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 207 MIDDLE EAST: GENE EXPRESSION DATABASES MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 208 GCC COUNTRIES: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 209 GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 210 NORTH AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 211 EUROPE: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 212 ASIA PACIFIC: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 213 LATIN AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 214 MIDDLE EAST: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 215 GCC COUNTRIES: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 216 CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 217 NORTH AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 218 EUROPE: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 219 ASIA PACIFIC: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 220 LATIN AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 221 MIDDLE EAST: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 222 GCC COUNTRIES: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 223 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 206 TABLE 224 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 225 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 226 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 227 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 228 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 229 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 230 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 231 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 232 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 233 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 234 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 235 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 236 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 237 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 238 GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 239 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 240 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 241 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 242 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 243 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 216 TABLE 244 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 245 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 246 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 247 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 248 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 249 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 250 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 251 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 252 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 221 TABLE 253 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 254 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 255 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 256 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 257 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 258 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 259 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 260 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 261 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 262 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 263 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 264 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 265 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 266 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 267 GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 268 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 269 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 270 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 271 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 272 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 273 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 274 GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 275 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 276 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 277 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 278 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 279 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 280 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 281 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 282 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 283 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 284 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 285 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 286 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 238 TABLE 287 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 288 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 289 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 290 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 242 TABLE 291 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 292 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 293 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 294 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 295 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 296 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 297 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 298 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 246 TABLE 299 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 246 TABLE 300 US: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 247 TABLE 301 US: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 302 US: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 303 US: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 304 US: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 305 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 306 US: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 307 US: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 308 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 251 TABLE 309 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 252 TABLE 310 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 253 TABLE 311 CANADA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 312 CANADA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 313 CANADA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 314 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 315 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 316 CANADA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 317 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 318 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 257 TABLE 319 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 257 TABLE 320 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 321 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 258 TABLE 322 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 323 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 324 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 325 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 326 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 327 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 328 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 329 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 262 TABLE 330 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 263 TABLE 331 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 264 TABLE 332 GERMANY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 333 GERMANY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 334 GERMANY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 335 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 336 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 337 GERMANY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 338 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 339 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 267 TABLE 340 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 268 TABLE 341 UK: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 269 TABLE 342 UK: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 343 UK: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 344 UK: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 345 UK: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 346 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 347 UK: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 348 UK: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 349 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 272 TABLE 350 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 273 TABLE 351 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 274 TABLE 352 FRANCE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 353 FRANCE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 354 FRANCE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 355 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 356 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 357 FRANCE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 358 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 359 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 277 TABLE 360 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 278 TABLE 361 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 279 TABLE 362 ITALY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 363 ITALY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 364 ITALY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 365 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 366 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 367 ITALY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 368 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 369 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 282 TABLE 370 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 371 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 284 TABLE 372 SPAIN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 373 SPAIN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 374 SPAIN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 375 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 376 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 377 SPAIN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 378 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 379 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 287 TABLE 380 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 288 TABLE 381 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 289 TABLE 382 REST OF EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 383 REST OF EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 384 REST OF EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 385 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 386 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 387 REST OF EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 388 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 389 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 292 TABLE 390 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 293 TABLE 391 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 294 TABLE 392 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 295 TABLE 393 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 394 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 395 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 396 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 397 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 398 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 399 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 400 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 298 TABLE 401 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 299 TABLE 402 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 300 TABLE 403 CHINA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 404 CHINA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 405 CHINA GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 406 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 407 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 408 CHINA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 409 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 410 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 303 TABLE 411 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 304 TABLE 412 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 305 TABLE 413 JAPAN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 414 JAPAN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 415 JAPAN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 416 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 417 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 418 JAPAN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 419 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 420 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 308 TABLE 421 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 309 TABLE 422 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 310 TABLE 423 INDIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 424 INDIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 425 INDIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 426 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 427 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 428 INDIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 429 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 430 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 313 TABLE 431 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 314 TABLE 432 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 315 TABLE 433 AUSTRALIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 434 AUSTRALIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 435 AUSTRALIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 436 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 437 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 438 AUSTRALIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 439 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 440 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 318 TABLE 441 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 319 TABLE 442 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 320 TABLE 443 SOUTH KOREA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 444 SOUTH KOREA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 445 SOUTH KOREA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 446 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 447 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 448 SOUTH KOREA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 449 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 450 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 323 TABLE 451 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 324 TABLE 452 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 325 TABLE 453 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 454 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 455 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 456 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 457 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 458 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 459 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 460 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 328 TABLE 461 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 329 TABLE 462 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 463 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 330 TABLE 464 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 465 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 466 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 467 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 468 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 469 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 470 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 471 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 333 TABLE 472 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 334 TABLE 473 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024–2031 (USD MILLION) 335 TABLE 474 BRAZIL: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 475 BRAZIL: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 476 BRAZIL: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 477 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 478 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 479 BRAZIL: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 480 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 481 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 338 TABLE 482 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 339 TABLE 483 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024–2031 (USD MILLION) 340 TABLE 484 MEXICO: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 485 MEXICO: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 486 MEXICO: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 487 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 488 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 489 MEXICO: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 490 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 491 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 343 TABLE 492 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 344 TABLE 493 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 345 TABLE 494 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 495 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 496 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 497 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 498 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 499 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 500 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 501 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 348 TABLE 502 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 349 TABLE 503 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 349 TABLE 504 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 350 TABLE 505 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 506 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 507 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 508 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 509 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 510 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 511 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 512 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 353 TABLE 513 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 353 TABLE 514 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 515 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 354 TABLE 516 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 517 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 518 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 519 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 520 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 521 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 522 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 523 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 357 TABLE 524 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 358 TABLE 525 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 359 TABLE 526 SAUDI ARABIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 527 SAUDI ARABIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 528 SAUDI ARABIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 529 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 530 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 531 SAUDI ARABIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 532 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 533 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 362 TABLE 534 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 363 TABLE 535 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 364 TABLE 536 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 537 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 538 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 539 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 540 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 541 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 542 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 543 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 367 TABLE 544 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 368 TABLE 545 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 369 TABLE 546 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 547 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 548 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 549 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 550 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 551 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 552 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 553 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 372 TABLE 554 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 373 TABLE 555 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 374 TABLE 556 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 557 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 558 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 559 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 560 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 561 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 562 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 563 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 377 TABLE 564 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 378 TABLE 565 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 379 TABLE 566 AFRICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 567 AFRICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 568 AFRICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 569 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 570 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 571 AFRICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 572 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 573 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 382 TABLE 574 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 383 TABLE 575 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023–MARCH 2026 384 TABLE 576 GENE EXPRESSION ANALYSIS MARKET: DEGREE OF COMPETITION 388 TABLE 577 GENE EXPRESSION ANALYSIS MARKET: REGION FOOTPRINT 394 TABLE 578 GENE EXPRESSION ANALYSIS MARKET: OFFERING FOOTPRINT 395 TABLE 579 GENE EXPRESSION ANALYSIS MARKET: APPLICATION FOOTPRINT 396 TABLE 580 GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 399 TABLE 581 GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 400 TABLE 582 GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 402 TABLE 583 GENE EXPRESSION ANALYSIS MARKET: DEALS, JANUARY 2023– MARCH 2026 403 TABLE 584 GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS, JANUARY 2023– MARCH 2026 403 TABLE 585 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 404 TABLE 586 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 405 TABLE 587 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 409 TABLE 588 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023– MARCH 2026 410 TABLE 589 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023– MARCH 2026 410 TABLE 590 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 412 TABLE 591 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 414 TABLE 592 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 417 TABLE 593 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023– MARCH 2026 418 TABLE 594 ILLUMINA, INC.: COMPANY OVERVIEW 419 TABLE 595 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 420 TABLE 596 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 423 TABLE 597 ILLUMINA, INC.: DEALS, JANUARY 2023– MARCH 2026 424 TABLE 598 QIAGEN: COMPANY OVERVIEW 425 TABLE 599 QIAGEN: PRODUCTS/SERVICES OFFERED 426 TABLE 600 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 431 TABLE 601 QIAGEN: DEALS, JANUARY 2023– MARCH 2026 431 TABLE 602 REVVITY: COMPANY OVERVIEW 433 TABLE 603 REVVITY: PRODUCTS/SERVICES OFFERED 434 TABLE 604 REVVITY: DEALS, JANUARY 2023– MARCH 2026 436 TABLE 605 REVVITY: EXPANSIONS, JANUARY 2023– MARCH 2026 436 TABLE 606 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 438 TABLE 607 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 439 TABLE 608 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 440 TABLE 609 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023– MARCH 2026 441 TABLE 610 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023– MARCH 2026 441 TABLE 611 PACBIO: COMPANY OVERVIEW 442 TABLE 612 PACBIO: PRODUCTS/SERVICES OFFERED 443 TABLE 613 PACBIO: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 444 TABLE 614 PACBIO: DEALS, JANUARY 2023– MARCH 2026 444 TABLE 615 PACBIO: EXPANSIONS, JANUARY 2023– MARCH 2026 445 TABLE 616 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 446 TABLE 617 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 447 TABLE 618 SYSMEX CORPORATION: COMPANY OVERVIEW 451 TABLE 619 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED 452 TABLE 620 SYSMEX CORPORATION: DEALS, JANUARY 2023– MARCH 2026 453 TABLE 621 SYSMEX CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023– MARCH 2026 453 TABLE 622 BGI: COMPANY OVERVIEW 454 TABLE 623 BGI: PRODUCTS/SERVICES OFFERED 454 TABLE 624 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 456 TABLE 625 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 457 TABLE 626 STANDARD BIOTOOLS: COMPANY OVERVIEW 458 TABLE 627 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED 459 TABLE 628 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 460 TABLE 629 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 461 TABLE 630 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED 462 TABLE 631 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023– MARCH 2026 463 TABLE 632 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023– MARCH 2026 464 TABLE 633 GENSCRIPT: COMPANY OVERVIEW 465 TABLE 634 GENSCRIPT: PRODUCTS/SERVICES OFFERED 466 TABLE 635 GENSCRIPT: DEALS, JANUARY 2023– MARCH 2026 467 TABLE 636 GENSCRIPT: EXPANSIONS, JANUARY 2023– MARCH 2026 467 TABLE 637 TAKARA BIO INC.: COMPANY OVERVIEW 468 TABLE 638 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 469 TABLE 639 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2023– MARCH 2026 473 TABLE 640 TAKARA BIO INC.: DEALS, JANUARY 2023– MARCH 2026 474 TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW 475 TABLE 642 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 476 TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2023– MARCH 2026 476 TABLE 644 BRUKER: COMPANY OVERVIEW 477 TABLE 645 BRUKER: PRODUCTS/SERVICES OFFERED 479 TABLE 646 BRUKER: DEALS, JANUARY 2023– MARCH 2026 479 TABLE 647 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 501 TABLE 648 RISK ASSESSMENT 502 FIGURE 1 GENE EXPRESSION ANALYSIS MARKET SEGMENTATION AND REGIONS CONSIDERED 45 FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: YEARS CONSIDERED 46 FIGURE 3 MARKET SCENARIO 49 FIGURE 4 GLOBAL GENE EXPRESSION ANALYSIS MARKET, 2024–2031 50 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, 2023–2026 50 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF GENE EXPRESSION ANALYSIS MARKET 51 FIGURE 7 HIGH-GROWTH SEGMENTS IN GENE EXPRESSION ANALYSIS MARKET, 2026–2031 52 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GENE EXPRESSION ANALYSIS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 53 FIGURE 9 GROWING USE OF GENE EXPRESSION ANALYSIS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH 54 FIGURE 10 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF GENE EXPRESSION ANALYSIS MARKET IN NORTH AMERICA IN 2025 55 FIGURE 11 ASIA PACIFIC COUNTRIES TO REGISTER HIGH GROWTH RATES DURING FORECAST PERIOD 56 FIGURE 12 REAGENTS & CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD 56 FIGURE 13 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 FIGURE 14 GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 66 FIGURE 15 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS 69 FIGURE 16 GENE EXPRESSION ANALYSIS MARKET: ECOSYSTEM ANALYSIS 71 FIGURE 17 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2025 (USD) 73 FIGURE 18 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD) 74 FIGURE 19 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2025 (USD) 75 FIGURE 20 AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD) 76 FIGURE 21 GENE EXPRESSION ANALYSIS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82 FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023–2025 (USD MILLION) 83 FIGURE 23 PATENT APPLICATIONS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2015–DECEMBER 2025 93 FIGURE 24 IMPACT OF AI/GEN AI ON GENE EXPRESSION ANALYSIS MARKET 96 FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 106 FIGURE 26 KEY BUYING CRITERIA, BY END USER 107 FIGURE 27 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 241 FIGURE 28 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 294 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE GENE EXPRESSION ANALYSIS MARKET, 2021–2025 (USD MILLION) 386 FIGURE 30 MARKET SHARE ANALYSIS, 2025 387 FIGURE 31 GENE EXPRESSION ANALYSIS MARKET: BRAND COMPARATIVE ANALYSIS 390 FIGURE 32 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 392 FIGURE 33 GENE EXPRESSION ANALYSIS MARKET: COMPANY FOOTPRINT 393 FIGURE 34 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 398 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 401 FIGURE 36 EV/EBITDA OF KEY VENDORS 401 FIGURE 37 THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2025) 405 FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 413 FIGURE 39 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 420 FIGURE 40 QIAGEN: COMPANY SNAPSHOT (2025) 426 FIGURE 41 REVVITY: COMPANY SNAPSHOT (2025) 434 FIGURE 42 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 439 FIGURE 43 PACBIO: COMPANY SNAPSHOT (2025) 442 FIGURE 44 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2025) 447 FIGURE 45 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024) 451 FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 457 FIGURE 47 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2025) 458 FIGURE 48 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2025) 462 FIGURE 49 GENSCRIPT: COMPANY SNAPSHOT (2024) 465 FIGURE 50 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 469 FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 475 FIGURE 52 BRUKER: COMPANY SNAPSHOT (2025) 478 FIGURE 53 GENE EXPRESSION ANALYSIS MARKET: RESEARCH DESIGN 491 FIGURE 54 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 493 FIGURE 55 GENE EXPRESSION ANALYSIS MARKET: INSIGHTS FROM PRIMARIES 494 FIGURE 56 GLOBAL GENE EXPRESSION ANALYSIS MARKET ESTIMATION, 2025 495 FIGURE 57 GENE EXPRESSION ANALYSIS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025) 496 FIGURE 58 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025) 496 FIGURE 59 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 498 FIGURE 60 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS 499 FIGURE 61 GENE EXPRESSION ANALYSIS MARKET: DATA TRIANGULATION 500

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們